PositiveID Mid-Year Update: Company Advances FireflyDX Testing and Partnership Discussions, and Expands Caregiver Market Penetration DELRAY BEACH, Fla., May 30, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, is proud to...

PositiveID Announces Highlights for the Third Quarter of 2017 PositiveID’s ExcitePCR subsidiary announces new product, the FireflyDX-Portable, with commercial availability scheduled for late 2018 Company Successfully detects Ebola Virus on FireflyDX...

PositiveID Achieves Firefly Dx Development Milestone With the Production of Injection-Molded PCR Chips DELRAY BEACH, Fla., Aug. 26, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced...

PositiveID Provides Mid-Year Update and Highlights Its Progress With Firefly Dx Development DELRAY BEACH, Fla., June 29, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, provided a...

PositiveID Corporation Achieves Firefly Dx Development Milestone With Completion of Breadboard PCR DELRAY BEACH, Fla., Feb. 12, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced...